Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Nov 2009

Myers Andrea P, Meyerhardt Jeffrey A, Cantley Lewis C

Abstract excerpt

There is high morbidity associated with local recurrence of rectal cancer. However, the adjuvant therapies given to prevent such recurrences also have significant side effects and associated risks. The ability to select patients with the highest risk of recurrence and greatest therapeutic respons...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to Combined Modality Therapy
Share to Medical Oncology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Biological

Share to Phosphatidylinositol 3-Kinases

Share to Rectal Neoplasms

Share to Recurrence

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 19903790
DOI: 10.1158/1078-0432.CCR-09-2305
PMCID: PMC3400141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19903790-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?PMID 19903790Read ↗

PIK3CA mutations predict local recurrences in rectal cancer patients.Semantic proximity Read ↗

From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer.Semantic proximity Read ↗

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.Semantic proximity Read ↗

KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.Semantic proximity Read ↗

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.Semantic proximity Read ↗

Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer.Semantic proximity Read ↗

Molecular Markers Beyond Microsatellite Instability for Assessing Prognosis in Early-Stage Colorectal Cancer: What Happens at Relapse?Semantic proximity Read ↗

Response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT pathway dysregulation and high tumour mutational burdenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.